“PHARMACOGENOMIC VARIABILITY IN CHEMOTHERAPEUTIC DRUG RESPONSE AMONG CANCER PATIENTS”, GJAB, vol. 3, no. 02, pp. 31–48, Dec. 2025, doi: 10.66406/gjab02202581.